Brief: Adial Pharmaceuticals Receives Notice Of Allowance On U.S. Patent For Treatment For Opioid Use Disorder Using Ad04

Azora Therapeutics

24/01/2022 14:48

Jan 24 (Reuters) - Adial Pharmaceuticals Inc  ADIL.O :
    * ADIAL PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE ON U.S.
PATENT FOR TREATMENT FOR OPIOID USE DISORDER USING AD04
    * ADIAL PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE ON U.S.
PATENT FOR THE TREATMENT FOR OPIOID USE DISORDER USING AD04
    * ADIAL PHARMACEUTICALS INC - ISSUED PATENT WOULD HAVE A
TERM THAT
EXPIRES NO EARLIER THAN JULY 1, 2031

Source text for Eikon:  ID:nGNX2f25Zq 
Further company coverage:  ADIL.O 

 ((Reuters.Briefs@thomsonreuters.com;))